Qinghai Spring Medicinal Resources Technology Co Ltd
Qinghai Spring Medicinal Resources Technology Co., Ltd. manufactures and sells alcoholic beverages and health products in China. It operates through two segments, Wine and Beverage Fast-Moving Consumer Goods and Big Health. The Wine and Beverage Fast-Moving Consumer Goods segment focuses on the sales of alcoholic beverages, including the Tinghua series wines. The Big Health segment engages in the… Read more
Qinghai Spring Medicinal Resources Technology Co Ltd (600381) - Total Liabilities
Latest total liabilities as of September 2025: CN¥45.34 Million CNY
Based on the latest financial reports, Qinghai Spring Medicinal Resources Technology Co Ltd (600381) has total liabilities worth CN¥45.34 Million CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Qinghai Spring Medicinal Resources Technology Co Ltd - Total Liabilities Trend (1998–2024)
This chart illustrates how Qinghai Spring Medicinal Resources Technology Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Qinghai Spring Medicinal Resources Technology Co Ltd Competitors by Total Liabilities
The table below lists competitors of Qinghai Spring Medicinal Resources Technology Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kuo Yang Construction Co Ltd
TW:2505
|
Taiwan | NT$11.93 Billion |
|
CTT Systems AB
ST:CTT
|
Sweden | Skr93.80 Million |
|
Unicycive Therapeutics Inc
NASDAQ:UNCY
|
USA | $13.13 Million |
|
GZ4
F:GZ4
|
Germany | €5.37 Billion |
|
Forest Packaging Group Co Ltd
SHG:605500
|
China | CN¥1.62 Billion |
|
MK Electron Co. Ltd
KQ:033160
|
Korea | ₩1.48 Trillion |
|
Qijing Machinery
SHG:603677
|
China | CN¥1.08 Billion |
|
Enli Technology Co.,Ltd
TWO:7728
|
Taiwan | NT$156.84 Million |
Liability Composition Analysis (1998–2024)
This chart breaks down Qinghai Spring Medicinal Resources Technology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 12.39 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.04 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.04 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Qinghai Spring Medicinal Resources Technology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Qinghai Spring Medicinal Resources Technology Co Ltd (1998–2024)
The table below shows the annual total liabilities of Qinghai Spring Medicinal Resources Technology Co Ltd from 1998 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥128.02 Million | +39.17% |
| 2023-12-31 | CN¥91.99 Million | +249.80% |
| 2022-12-31 | CN¥26.30 Million | -4.85% |
| 2021-12-31 | CN¥27.64 Million | -79.84% |
| 2020-12-31 | CN¥137.08 Million | +580.80% |
| 2019-12-31 | CN¥20.14 Million | -61.78% |
| 2018-12-31 | CN¥52.68 Million | -53.61% |
| 2017-12-31 | CN¥113.56 Million | -45.13% |
| 2016-12-31 | CN¥206.95 Million | -41.64% |
| 2015-12-31 | CN¥354.60 Million | -68.53% |
| 2014-12-31 | CN¥1.13 Billion | -21.69% |
| 2013-12-31 | CN¥1.44 Billion | -24.25% |
| 2012-12-31 | CN¥1.90 Billion | +17.40% |
| 2011-12-31 | CN¥1.62 Billion | +72.39% |
| 2010-12-31 | CN¥938.58 Million | +78.57% |
| 2009-12-31 | CN¥525.60 Million | -10.77% |
| 2008-12-31 | CN¥589.02 Million | -16.76% |
| 2007-12-31 | CN¥707.61 Million | -18.04% |
| 2006-12-31 | CN¥863.38 Million | -17.39% |
| 2005-12-31 | CN¥1.05 Billion | -14.60% |
| 2004-12-31 | CN¥1.22 Billion | +54.93% |
| 2003-12-31 | CN¥789.85 Million | +89.91% |
| 2002-12-31 | CN¥415.90 Million | +56.98% |
| 2001-12-31 | CN¥264.94 Million | +41.00% |
| 2000-12-31 | CN¥187.91 Million | +46.76% |
| 1999-12-31 | CN¥128.04 Million | +7.16% |
| 1998-12-31 | CN¥119.48 Million | -- |